Mimicking Aspects of Frontotemporal Lobar Degeneration and Lou Gehrig's Disease in Rats via TDP-43 Overexpression

Since the discovery of neuropathological lesions made of TDP-43 and ubiquitin proteins in cases of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), there is a burst of effort on finding related familial mutations and developing animal models. We used an adeno-associa...

Full description

Saved in:
Bibliographic Details
Published inMolecular therapy Vol. 17; no. 4; pp. 607 - 613
Main Authors Tatom, Jason B, Wang, David B, Dayton, Robert D, Skalli, Omar, Hutton, Michael L, Dickson, Dennis W, Klein, Ronald L
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.04.2009
Elsevier Limited
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Since the discovery of neuropathological lesions made of TDP-43 and ubiquitin proteins in cases of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), there is a burst of effort on finding related familial mutations and developing animal models. We used an adeno-associated virus (AAV) vector for human TDP-43 expression targeted to the substantia nigra (SN) of rats. Though TDP-43 was expressed mainly in neuronal nuclei as expected, it was also expressed in the cytoplasm, and dotted along the plasma membrane of neurons. Cytoplasmic staining was both diffuse and granular, indicative of preinclusion lesions, over 4 weeks. Ubiquitin deposited in the cytoplasm, specifically in the TDP-43 group, and staining for microglia was increased dose-dependently by 1–2 logs in the TDP-43 group, while neurons were selectively obliterated. Neuronal death induced by TDP-43 was pyknotic and apoptotic. TDP-43 gene transfer caused loss of dopaminergic neurons in the SN and their axons in the striatum. Behavioral motor dysfunction resulted after TDP-43 gene transfer that was vector dose-dependent and progressive over time. The cytoplasmic expression, ubiquitination, and neurodegeneration mimicked features of the TDP-43 diseases, and the gliosis, apoptosis, and motor impairment may also be relevant to TDP-43 disease forms involving nigrostriatal degeneration.
AbstractList Since the discovery of neuropathological lesions made of TDP-43 and ubiquitin proteins in cases of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), there is a burst of effort on finding related familial mutations and developing animal models. We used an adeno-associated virus (AAV) vector for human TDP-43 expression targeted to the substantia nigra (SN) of rats. Though TDP-43 was expressed mainly in neuronal nuclei as expected, it was also expressed in the cytoplasm, and dotted along the plasma membrane of neurons. Cytoplasmic staining was both diffuse and granular, indicative of preinclusion lesions, over 4 weeks. Ubiquitin deposited in the cytoplasm, specifically in the TDP-43 group, and staining for microglia was increased dose-dependently by 1-2 logs in the TDP-43 group, while neurons were selectively obliterated. Neuronal death induced by TDP-43 was pyknotic and apoptotic. TDP-43 gene transfer caused loss of dopaminergic neurons in the SN and their axons in the striatum. Behavioral motor dysfunction resulted after TDP-43 gene transfer that was vector dose-dependent and progressive over time. The cytoplasmic expression, ubiquitination, and neurodegeneration mimicked features of the TDP-43 diseases, and the gliosis, apoptosis, and motor impairment may also be relevant to TDP-43 disease forms involving nigrostriatal degeneration.
Since the discovery of neuropathological lesions made of TDP-43 and ubiquitin proteins in cases of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), there is a burst of effort on finding related familial mutations and developing animal models. We used an adeno-associated virus (AAV) vector for human TDP-43 expression targeted to the substantia nigra (SN) of rats. Though TDP-43 was expressed mainly in neuronal nuclei as expected, it was also expressed in the cytoplasm, and dotted along the plasma membrane of neurons. Cytoplasmic staining was both diffuse and granular, indicative of preinclusion lesions, over 4 weeks. Ubiquitin deposited in the cytoplasm, specifically in the TDP-43 group, and staining for microglia was increased dose-dependently by 1–2 logs in the TDP-43 group, while neurons were selectively obliterated. Neuronal death induced by TDP-43 was pyknotic and apoptotic. TDP-43 gene transfer caused loss of dopaminergic neurons in the SN and their axons in the striatum. Behavioral motor dysfunction resulted after TDP-43 gene transfer that was vector dose-dependent and progressive over time. The cytoplasmic expression, ubiquitination, and neurodegeneration mimicked features of the TDP-43 diseases, and the gliosis, apoptosis, and motor impairment may also be relevant to TDP-43 disease forms involving nigrostriatal degeneration.
Since the discovery of neuropathological lesions made of TDP-43 and ubiquitin proteins in cases of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), there is a burst of effort on finding related familial mutations and developing animal models. We used an adeno-associated virus (AAV) vector for human TDP-43 expression targeted to the substantia nigra (SN) of rats. Though TDP-43 was expressed mainly in neuronal nuclei as expected, it was also expressed in the cytoplasm, and dotted along the plasma membrane of neurons. Cytoplasmic staining was both diffuse and granular, indicative of preinclusion lesions, over 4 weeks. Ubiquitin deposited in the cytoplasm, specifically in the TDP-43 group, and staining for microglia was increased dose-dependently by 1-2 logs in the TDP-43 group, while neurons were selectively obliterated. Neuronal death induced by TDP-43 was pyknotic and apoptotic. TDP-43 gene transfer caused loss of dopaminergic neurons in the SN and their axons in the striatum. Behavioral motor dysfunction resulted after TDP-43 gene transfer that was vector dose-dependent and progressive over time. The cytoplasmic expression, ubiquitination, and neurodegeneration mimicked features of the TDP-43 diseases, and the gliosis, apoptosis, and motor impairment may also be relevant to TDP-43 disease forms involving nigrostriatal degeneration.Since the discovery of neuropathological lesions made of TDP-43 and ubiquitin proteins in cases of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS), there is a burst of effort on finding related familial mutations and developing animal models. We used an adeno-associated virus (AAV) vector for human TDP-43 expression targeted to the substantia nigra (SN) of rats. Though TDP-43 was expressed mainly in neuronal nuclei as expected, it was also expressed in the cytoplasm, and dotted along the plasma membrane of neurons. Cytoplasmic staining was both diffuse and granular, indicative of preinclusion lesions, over 4 weeks. Ubiquitin deposited in the cytoplasm, specifically in the TDP-43 group, and staining for microglia was increased dose-dependently by 1-2 logs in the TDP-43 group, while neurons were selectively obliterated. Neuronal death induced by TDP-43 was pyknotic and apoptotic. TDP-43 gene transfer caused loss of dopaminergic neurons in the SN and their axons in the striatum. Behavioral motor dysfunction resulted after TDP-43 gene transfer that was vector dose-dependent and progressive over time. The cytoplasmic expression, ubiquitination, and neurodegeneration mimicked features of the TDP-43 diseases, and the gliosis, apoptosis, and motor impairment may also be relevant to TDP-43 disease forms involving nigrostriatal degeneration.
Author Wang, David B
Dayton, Robert D
Hutton, Michael L
Dickson, Dennis W
Tatom, Jason B
Klein, Ronald L
Skalli, Omar
AuthorAffiliation 6 Gene Therapy Program, Louisiana State University Health Sciences Center Shreveport, Louisiana, USA
3 Neuroscience Drug Discovery, Merck Research Labs Boston, Massachusetts, USA
4 Department of Pathology, Mayo Clinic Jacksonville Jacksonville, Florida, USA
2 Department of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center Shreveport, Louisiana, USA
5 Department of Neuroscience, Mayo Clinic Jacksonville Jacksonville, Florida, USA
1 Department of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center Shreveport, Louisiana, USA
AuthorAffiliation_xml – name: 6 Gene Therapy Program, Louisiana State University Health Sciences Center Shreveport, Louisiana, USA
– name: 3 Neuroscience Drug Discovery, Merck Research Labs Boston, Massachusetts, USA
– name: 5 Department of Neuroscience, Mayo Clinic Jacksonville Jacksonville, Florida, USA
– name: 4 Department of Pathology, Mayo Clinic Jacksonville Jacksonville, Florida, USA
– name: 2 Department of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center Shreveport, Louisiana, USA
– name: 1 Department of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center Shreveport, Louisiana, USA
Author_xml – sequence: 1
  givenname: Jason B
  surname: Tatom
  fullname: Tatom, Jason B
  organization: Department of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
– sequence: 2
  givenname: David B
  surname: Wang
  fullname: Wang, David B
  organization: Department of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
– sequence: 3
  givenname: Robert D
  surname: Dayton
  fullname: Dayton, Robert D
  organization: Department of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
– sequence: 4
  givenname: Omar
  surname: Skalli
  fullname: Skalli, Omar
  organization: Department of Cellular Biology and Anatomy, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
– sequence: 5
  givenname: Michael L
  surname: Hutton
  fullname: Hutton, Michael L
  organization: Neuroscience Drug Discovery, Merck Research Labs, Boston, Massachusetts, USA
– sequence: 6
  givenname: Dennis W
  surname: Dickson
  fullname: Dickson, Dennis W
  organization: Department of Pathology, Mayo Clinic Jacksonville, Jacksonville, Florida, USA
– sequence: 7
  givenname: Ronald L
  surname: Klein
  fullname: Klein, Ronald L
  email: klein@lsuhsc.edu
  organization: Department of Pharmacology, Toxicology, and Neuroscience, Louisiana State University Health Sciences Center, Shreveport, Louisiana, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/19223871$$D View this record in MEDLINE/PubMed
BookMark eNptkd1rFDEUxYNU7Ic--A9IQFB8mG0-JvPxIpSurcJKRepzuJO5s03dSaZJZtH_3tStVUufckl-53BPziHZc94hIS85W3Amm-MxLQRj7UI-IQdcCVUwJsq9-5lX--Qwxus8cdVWz8g-b4WQTc0PyM1nO1rz3bo1PYkTmhSpH-hZ8C75hOPkA2zoyncQ6BLX6DBAst5RcH2-nuk5XgW7fhvp0kaEiNQ6-hWyy9YCvVx-KUpJL7YY8McUMMYsfU6eDrCJ-OLuPCLfzj5cnn4sVhfnn05PVoVRnKdCtpJhpxrEsutKiVAx6Ay0VdUPg2q4qIYS6p7VTc3aqpMGAIVsq7oG4H3J5BF5v_Od5m7E3qBLOYuegh0h_NQerP7_xdkrvfZbLRqpOOPZ4M2dQfA3M8akRxsNbjbg0M9RVzVnQtUqg68fgNd-Di6H07xuhWpLXpaZevXvPveL_OkiA-92gAk-xoDDX4Tp2571mPRtz1pm9vgBa2z63UyOYjePKuROgfnPtxaDjsaiM9jbkGvXvbePqH4BRna8hA
CitedBy_id crossref_primary_10_1016_j_celrep_2024_113999
crossref_primary_10_1371_journal_pgen_1000887
crossref_primary_10_1016_j_jocn_2017_03_035
crossref_primary_10_1007_s00401_009_0571_7
crossref_primary_10_1007_s12640_009_9080_7
crossref_primary_10_1016_j_brainres_2009_01_063
crossref_primary_10_1146_annurev_neuro_060909_153144
crossref_primary_10_1007_s00401_011_0850_y
crossref_primary_10_3390_ijms141020079
crossref_primary_10_1016_j_csm_2010_09_007
crossref_primary_10_1073_pnas_0912417107
crossref_primary_10_1016_j_febslet_2009_06_042
crossref_primary_10_1523_JNEUROSCI_2911_10_2010
crossref_primary_10_1111_j_1365_2990_2010_01060_x
crossref_primary_10_1038_gt_2014_101
crossref_primary_10_1038_mt_2013_88
crossref_primary_10_3109_01677063_2015_1077832
crossref_primary_10_1016_j_expneurol_2012_05_018
crossref_primary_10_1080_15548627_2021_1926656
crossref_primary_10_1007_s00401_011_0913_0
crossref_primary_10_1093_hmg_ddu152
crossref_primary_10_1038_ncomms5824
crossref_primary_10_1074_jbc_M110_194852
crossref_primary_10_3389_fnins_2022_818655
crossref_primary_10_1073_pnas_0913602107
crossref_primary_10_1371_journal_pone_0169291
crossref_primary_10_3389_fnana_2014_00016
crossref_primary_10_1097_NEN_0b013e3181ee7d85
crossref_primary_10_1007_s10571_009_9489_9
crossref_primary_10_1007_s00401_020_02222_x
crossref_primary_10_1093_hmg_ddp303
crossref_primary_10_1016_j_mcn_2019_103418
crossref_primary_10_1186_1750_1326_5_21
crossref_primary_10_1016_j_pneurobio_2011_04_006
crossref_primary_10_1515_revneuro_2014_0057
crossref_primary_10_1101_gad_194829_112
crossref_primary_10_1016_S1474_4422_10_70195_2
crossref_primary_10_1517_14712598_2012_681463
crossref_primary_10_1007_s12031_011_9625_0
crossref_primary_10_1111_j_1460_9568_2011_07803_x
crossref_primary_10_1016_j_nbd_2010_06_017
crossref_primary_10_1038_s41598_018_22858_w
crossref_primary_10_1080_15287394_2011_618967
crossref_primary_10_1101_cshperspect_a024463
crossref_primary_10_1111_iep_12006
crossref_primary_10_1111_jmp_12162
crossref_primary_10_1038_mt_2010_191
crossref_primary_10_1016_j_celrep_2024_115113
crossref_primary_10_1038_s41598_017_06953_y
crossref_primary_10_1515_REVNEURO_2010_21_4_251
crossref_primary_10_3389_fnmol_2014_00081
crossref_primary_10_1093_hmg_ddu216
crossref_primary_10_1111_neup_12058
crossref_primary_10_1093_jnen_nlx055
crossref_primary_10_1007_s11910_009_0052_3
crossref_primary_10_1016_j_brainres_2018_01_015
crossref_primary_10_1172_JCI130988
crossref_primary_10_1016_j_expneurol_2011_12_002
crossref_primary_10_1096_fj_201701529RR
crossref_primary_10_3390_ijms241512176
crossref_primary_10_1093_hmg_ddq137
crossref_primary_10_1016_j_biochi_2012_05_020
Cites_doi 10.1523/JNEUROSCI.3421-07.2007
10.1093/brain/awm065
10.1111/j.1471-4159.2007.05190.x
10.1126/science.1134108
10.1016/j.molmed.2008.09.001
10.1007/s00401-007-0285-7
10.1038/sj.mt.6300331
10.1002/ana.21344
10.1083/jcb.200702115
10.2741/2727
10.1001/archneur.65.5.636
10.1007/s00401-007-0226-5
10.1038/nature05016
10.1016/j.febslet.2008.05.024
10.1111/j.1750-3639.2007.00055.x
10.1111/j.1749-6632.2000.tb06904.x
10.1097/01.jnen.0000205147.39210.c7
10.1073/pnas.191107398
10.1093/brain/awm069
10.1111/j.1460-9568.2008.06161.x
10.1016/j.neulet.2006.03.001
10.1128/JVI.69.6.3584-3596.1995
10.1016/j.nbd.2005.02.001
10.1089/10430340252837206
10.1002/ana.21147
ContentType Journal Article
Copyright 2009 The American Society of Gene Therapy
Copyright Nature Publishing Group Apr 2009
Copyright 2009, The American Society of Gene Therapy 2009 The American Society of Gene Therapy
Copyright_xml – notice: 2009 The American Society of Gene Therapy
– notice: Copyright Nature Publishing Group Apr 2009
– notice: Copyright 2009, The American Society of Gene Therapy 2009 The American Society of Gene Therapy
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FE
8FH
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M7P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
7X8
5PM
DOI 10.1038/mt.2009.3
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
ProQuest Health & Medical Collection (NC LIVE)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Collection
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection (via ProQuest)
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
ProQuest Health & Medical Collection
Medical Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Biological Science Collection
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList ProQuest Central Student
MEDLINE


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1525-0024
EndPage 613
ExternalDocumentID PMC2835101
4072890261
19223871
10_1038_mt_2009_3
S1525001616315532
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations Louisiana
Florida
United States--US
GeographicLocations_xml – name: Louisiana
– name: Florida
– name: United States--US
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: R01 NS048450
GroupedDBID ---
--K
0R~
123
1B1
29M
2WC
36B
39C
3V.
4.4
53G
6I.
7X7
88E
8FE
8FH
8FI
8FJ
AACTN
AAEDW
AAFTH
AAIAV
AALRI
AAVLU
AAXUO
ABAWZ
ABJNI
ABMAC
ABUDA
ABUWG
ABVKL
ACGFO
ACGFS
ACPRK
ADBBV
ADFRT
ADJPV
ADMUD
ADQMX
AEDAW
AENEX
AFKRA
AFTJW
AGAYW
AHMBA
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
ASPBG
AVWKF
AZFZN
BAWUL
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
DIK
DU5
E3Z
EBS
EJD
EMB
EMOBN
F5P
FDB
FEDTE
FRP
FYUFA
GX1
HCIFZ
HMCUK
HVGLF
HYE
HZ~
IHE
JIG
JSO
KQ8
LG5
LK8
M1P
M41
M7P
NCXOZ
NQ-
O9-
OK1
P2P
PQQKQ
PROAC
PSQYO
RCE
RIG
RNS
RNTTT
ROL
RPM
RPZ
SEW
SSZ
SV3
TR2
UHS
UKHRP
W2D
XPP
ZA5
ZMT
AAMRU
AAYWO
AAYXX
ABDGV
ABWVN
ACRPL
ACVFH
ADCNI
ADNMO
ADVLN
AEUPX
AFPUW
AGCQF
AIGII
AKAPO
AKBMS
AKRWK
AKYEP
ALIPV
APXCP
CITATION
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EFKBS
EIF
NPM
PJZUB
PPXIY
PQGLB
7XB
8FK
AZQEC
DWQXO
GNUQQ
K9.
PKEHL
PQEST
PQUKI
7X8
5PM
ID FETCH-LOGICAL-c511t-3930eb58ee4bb43ea60abca966dff58126f4a7d0787096b3caae239677aa1d403
IEDL.DBID 7X7
ISSN 1525-0016
1525-0024
IngestDate Thu Aug 21 13:33:32 EDT 2025
Fri Jul 11 07:51:32 EDT 2025
Fri Jul 25 11:11:15 EDT 2025
Mon Jul 21 05:31:37 EDT 2025
Tue Jul 01 01:46:30 EDT 2025
Thu Apr 24 23:10:03 EDT 2025
Fri Feb 23 02:31:04 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License http://creativecommons.org/licenses/by-nc-nd/4.0
https://www.elsevier.com/tdm/userlicense/1.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c511t-3930eb58ee4bb43ea60abca966dff58126f4a7d0787096b3caae239677aa1d403
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://dx.doi.org/10.1038/mt.2009.3
PMID 19223871
PQID 1792594144
PQPubID 2042164
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2835101
proquest_miscellaneous_67102575
proquest_journals_1792594144
pubmed_primary_19223871
crossref_primary_10_1038_mt_2009_3
crossref_citationtrail_10_1038_mt_2009_3
elsevier_sciencedirect_doi_10_1038_mt_2009_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2009-04-01
PublicationDateYYYYMMDD 2009-04-01
PublicationDate_xml – month: 04
  year: 2009
  text: 2009-04-01
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Milwaukee
PublicationTitle Molecular therapy
PublicationTitleAlternate Mol Ther
PublicationYear 2009
Publisher Elsevier Inc
Elsevier Limited
Nature Publishing Group
Publisher_xml – name: Elsevier Inc
– name: Elsevier Limited
– name: Nature Publishing Group
References Baker, Mackenzie, Pickering-Brown, Gass, Rademakers, Lindholm (bib8) 2006; 442
Mackenzie, Bigio, Ince, Geser, Neumann, Cairns (bib10) 2007; 61
Pirici, Vandenberghe, Rademakers, Dermaut, Cruts, Vennekens (bib7) 2006; 65
Hasegawa, Arai, Akiyama, Nonaka, Mori, Hashimoto (bib18) 2007; 130
Winton, Van Deerlin, Kwong, Yuan, Wood, Yu (bib21) 2008; 582
Neumann (bib2) 2008; 26
Wang, Wu, Shen (bib6) 2008; 14
Neary, Snowden, Mann (bib3) 2000; 920
Klein, Dayton, Lin, Dickson (bib12) 2005; 20
Kumar-Singh, Van Broeckhoven (bib1) 2007; 17
Klein, Dayton, Henderson, Petrucelli (bib25) 2006; 401
Klein, Dayton, Tatom, Diaczynsky, Salvatore (bib13) 2008; 27
Wider, Dickson, Stoessl, Tsuboi, Chapon, Gutmann (bib17) 2008
Buratti, Baralle (bib5) 2008; 13
Neumann, Sampathu, Kwong, Truax, Micsenyi, Chou (bib9) 2006; 314
Mochizuki, Hayakawa, Migita, Shibata, Tanaka, Suzuki (bib26) 2001; 98
Klein, King, Hamby, Meyer (bib11) 2002; 13
Gitcho, Baloh, Chakraverty, Mayo, Norton, Levitch (bib22) 2008; 63
Paxinos, Watson (bib29) 1998
Kwong, Neumann, Sampathu, Lee, Trojanowski (bib20) 2007; 114
Ou, Wu, Harrich, García-Martínez, Gaynor (bib4) 1995; 69
Geser, Brandmeir, Kwong, Martinez-Lage, Elman, McCluskey (bib15) 2008; 65
Zhang, Xu, Dickey, Buratti, Baralle, Bailey (bib23) 2007; 27
Klein, Dayton, Diaczynsky, Wang (bib27) 2009
Zhang, Tan, Mori, Tanji, Kakita, Takahashi (bib16) 2008; 115
Klein, Dayton, Tatom, Henderson, Henning (bib19) 2008; 16
Leverenz, Yu, Montine, Steinbart, Bekris, Zabetian (bib14) 2007; 130
Filimonenko, Stuffers, Raiborg, Yamamoto, Malerød, Fisher (bib24) 2007; 179
Wang, Wu, Chang, Shen (bib28) 2008; 105
Klein (10.1038/mt.2009.3_bib11) 2002; 13
Geser (10.1038/mt.2009.3_bib15) 2008; 65
Wang (10.1038/mt.2009.3_bib6) 2008; 14
Buratti (10.1038/mt.2009.3_bib5) 2008; 13
Gitcho (10.1038/mt.2009.3_bib22) 2008; 63
Zhang (10.1038/mt.2009.3_bib23) 2007; 27
Pirici (10.1038/mt.2009.3_bib7) 2006; 65
Neumann (10.1038/mt.2009.3_bib9) 2006; 314
Neumann (10.1038/mt.2009.3_bib2) 2008; 26
Mochizuki (10.1038/mt.2009.3_bib26) 2001; 98
Baker (10.1038/mt.2009.3_bib8) 2006; 442
Paxinos (10.1038/mt.2009.3_bib29) 1998
Filimonenko (10.1038/mt.2009.3_bib24) 2007; 179
Leverenz (10.1038/mt.2009.3_bib14) 2007; 130
Hasegawa (10.1038/mt.2009.3_bib18) 2007; 130
Ou (10.1038/mt.2009.3_bib4) 1995; 69
Klein (10.1038/mt.2009.3_bib19) 2008; 16
Zhang (10.1038/mt.2009.3_bib16) 2008; 115
Mackenzie (10.1038/mt.2009.3_bib10) 2007; 61
Wider (10.1038/mt.2009.3_bib17) 2008
Klein (10.1038/mt.2009.3_bib25) 2006; 401
Klein (10.1038/mt.2009.3_bib12) 2005; 20
Klein (10.1038/mt.2009.3_bib27) 2009
Kumar-Singh (10.1038/mt.2009.3_bib1) 2007; 17
Kwong (10.1038/mt.2009.3_bib20) 2007; 114
Neary (10.1038/mt.2009.3_bib3) 2000; 920
Klein (10.1038/mt.2009.3_bib13) 2008; 27
Wang (10.1038/mt.2009.3_bib28) 2008; 105
Winton (10.1038/mt.2009.3_bib21) 2008; 582
16862116 - Nature. 2006 Aug 24;442(7105):916-9
17023659 - Science. 2006 Oct 6;314(5796):130-3
16554120 - Neurosci Lett. 2006 Jun 19;401(1-2):130-5
16651890 - J Neuropathol Exp Neurol. 2006 Mar;65(3):289-301
17786458 - Acta Neuropathol. 2008 Jan;115(1):115-22
11535810 - Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10918-23
17492294 - Acta Neuropathol. 2007 Jul;114(1):63-70
17984323 - J Cell Biol. 2007 Nov 5;179(3):485-500
17955025 - Mol Ther. 2008 Jan;16(1):89-96
18288693 - Ann Neurol. 2008 Apr;63(4):535-8
17439980 - Brain. 2007 May;130(Pt 5):1360-74
16137567 - Neurobiol Dis. 2005 Oct;20(1):64-73
18505686 - FEBS Lett. 2008 Jun 25;582(15):2252-6
17439983 - Brain. 2007 May;130(Pt 5):1386-94
7745706 - J Virol. 1995 Jun;69(6):3584-96
17469116 - Ann Neurol. 2007 May;61(5):427-34
11916484 - Hum Gene Ther. 2002 Mar 20;13(5):605-12
18723384 - Parkinsonism Relat Disord. 2009 May;15(4):281-6
17898224 - J Neurosci. 2007 Sep 26;27(39):10530-4
17493044 - Brain Pathol. 2007 Jan;17(1):104-14
18929508 - Trends Mol Med. 2008 Nov;14(11):479-85
18380664 - Eur J Neurosci. 2008 Apr;27(7):1615-25
17981595 - Front Biosci. 2008;13:867-78
18474740 - Arch Neurol. 2008 May;65(5):636-41
11193176 - Ann N Y Acad Sci. 2000;920:46-51
18088371 - J Neurochem. 2008 May;105(3):797-806
19155101 - Neurobiol Aging. 2010 Dec;31(12):2091-102
References_xml – volume: 14
  start-page: 479
  year: 2008
  end-page: 485
  ident: bib6
  article-title: TDP-43: An emerging new player in neurodegenerative diseases
  publication-title: Trends Mol Med
– volume: 114
  start-page: 63
  year: 2007
  end-page: 70
  ident: bib20
  article-title: TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease
  publication-title: Acta Neuropathol
– volume: 61
  start-page: 427
  year: 2007
  end-page: 434
  ident: bib10
  article-title: Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations
  publication-title: Ann Neurol
– volume: 13
  start-page: 605
  year: 2002
  end-page: 612
  ident: bib11
  article-title: Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra
  publication-title: Hum Gene Ther
– volume: 16
  start-page: 89
  year: 2008
  end-page: 96
  ident: bib19
  article-title: AAV 8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method
  publication-title: Mol Ther
– volume: 13
  start-page: 867
  year: 2008
  end-page: 878
  ident: bib5
  article-title: Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
  publication-title: Front Biosci
– year: 1998
  ident: bib29
  publication-title: The Rat Brain in Stereotaxic Coordinates
– volume: 65
  start-page: 289
  year: 2006
  end-page: 301
  ident: bib7
  article-title: Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family
  publication-title: J Neuropathol Exp Neurol
– volume: 17
  start-page: 104
  year: 2007
  end-page: 114
  ident: bib1
  article-title: Frontotemporal lobar degeneration: current concepts in the light of recent advances
  publication-title: Brain Pathol
– volume: 179
  start-page: 485
  year: 2007
  end-page: 500
  ident: bib24
  article-title: Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease
  publication-title: J Cell Biol
– volume: 920
  start-page: 46
  year: 2000
  end-page: 51
  ident: bib3
  article-title: Classification and description of frontotemporal dementias
  publication-title: Ann NY Acad Sci
– volume: 69
  start-page: 3584
  year: 1995
  end-page: 3596
  ident: bib4
  article-title: Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs
  publication-title: J Virol
– volume: 20
  start-page: 64
  year: 2005
  end-page: 73
  ident: bib12
  article-title: Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat
  publication-title: Neurobiol Dis
– volume: 105
  start-page: 797
  year: 2008
  end-page: 806
  ident: bib28
  article-title: TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor
  publication-title: J Neurochem
– volume: 63
  start-page: 535
  year: 2008
  end-page: 538
  ident: bib22
  article-title: TDP-43 A315T mutation in familial motor neuron disease
  publication-title: Ann Neurol
– volume: 115
  start-page: 115
  year: 2008
  end-page: 122
  ident: bib16
  article-title: TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia
  publication-title: Acta Neuropathol
– volume: 130
  start-page: 1360
  year: 2007
  end-page: 1374
  ident: bib14
  article-title: A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology
  publication-title: Brain
– volume: 65
  start-page: 636
  year: 2008
  end-page: 641
  ident: bib15
  article-title: Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis
  publication-title: Arch Neurol
– volume: 442
  start-page: 916
  year: 2006
  end-page: 919
  ident: bib8
  article-title: Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
  publication-title: Nature
– volume: 582
  start-page: 2252
  year: 2008
  end-page: 2256
  ident: bib21
  article-title: A90V TDP-43 variant results in the aberrant localization of TDP-43
  publication-title: FEBS Lett
– volume: 27
  start-page: 10530
  year: 2007
  end-page: 10534
  ident: bib23
  article-title: Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43
  publication-title: J Neurosci
– volume: 130
  start-page: 1386
  year: 2007
  end-page: 1394
  ident: bib18
  article-title: TDP-43 is deposited in the Guam parkinsonism-dementia complex brains
  publication-title: Brain
– volume: 26
  start-page: S1:1
  year: 2008
  ident: bib2
  article-title: Pathological spectrum of frontotemporal lobar degeneration
  publication-title: Dement Geriatr Cogn Disord
– year: 2009
  ident: bib27
  article-title: Pronounced microgliosis and neurodegeneration in aged rats after tau gene transfer
  publication-title: Neurobiol Aging
– volume: 401
  start-page: 130
  year: 2006
  end-page: 135
  ident: bib25
  article-title: Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model
  publication-title: Neurosci Lett
– volume: 98
  start-page: 10918
  year: 2001
  end-page: 10923
  ident: bib26
  article-title: An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease
  publication-title: Proc Natl Acad Sci USA
– year: 2008
  ident: bib17
  article-title: Pallidonigral TDP-43 pathology in Perry syndrome
  publication-title: Parkinsonism Relat Disord
– volume: 314
  start-page: 130
  year: 2006
  end-page: 133
  ident: bib9
  article-title: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
  publication-title: Science
– volume: 27
  start-page: 1615
  year: 2008
  end-page: 1625
  ident: bib13
  article-title: Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states
  publication-title: Eur J Neurosci
– volume: 27
  start-page: 10530
  year: 2007
  ident: 10.1038/mt.2009.3_bib23
  article-title: Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43
  publication-title: J Neurosci
  doi: 10.1523/JNEUROSCI.3421-07.2007
– volume: 130
  start-page: 1386
  year: 2007
  ident: 10.1038/mt.2009.3_bib18
  article-title: TDP-43 is deposited in the Guam parkinsonism-dementia complex brains
  publication-title: Brain
  doi: 10.1093/brain/awm065
– volume: 105
  start-page: 797
  year: 2008
  ident: 10.1038/mt.2009.3_bib28
  article-title: TDP-43, the signature protein of FTLD-U, is a neuronal activity-responsive factor
  publication-title: J Neurochem
  doi: 10.1111/j.1471-4159.2007.05190.x
– year: 2009
  ident: 10.1038/mt.2009.3_bib27
  article-title: Pronounced microgliosis and neurodegeneration in aged rats after tau gene transfer
  publication-title: Neurobiol Aging
– volume: 314
  start-page: 130
  year: 2006
  ident: 10.1038/mt.2009.3_bib9
  article-title: Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
  publication-title: Science
  doi: 10.1126/science.1134108
– volume: 14
  start-page: 479
  year: 2008
  ident: 10.1038/mt.2009.3_bib6
  article-title: TDP-43: An emerging new player in neurodegenerative diseases
  publication-title: Trends Mol Med
  doi: 10.1016/j.molmed.2008.09.001
– volume: 115
  start-page: 115
  year: 2008
  ident: 10.1038/mt.2009.3_bib16
  article-title: TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-007-0285-7
– volume: 16
  start-page: 89
  year: 2008
  ident: 10.1038/mt.2009.3_bib19
  article-title: AAV 8, 9, Rh10, Rh43 vector gene transfer in the rat brain: effects of serotype, promoter and purification method
  publication-title: Mol Ther
  doi: 10.1038/sj.mt.6300331
– volume: 63
  start-page: 535
  year: 2008
  ident: 10.1038/mt.2009.3_bib22
  article-title: TDP-43 A315T mutation in familial motor neuron disease
  publication-title: Ann Neurol
  doi: 10.1002/ana.21344
– volume: 179
  start-page: 485
  year: 2007
  ident: 10.1038/mt.2009.3_bib24
  article-title: Functional multivesicular bodies are required for autophagic clearance of protein aggregates associated with neurodegenerative disease
  publication-title: J Cell Biol
  doi: 10.1083/jcb.200702115
– year: 2008
  ident: 10.1038/mt.2009.3_bib17
  article-title: Pallidonigral TDP-43 pathology in Perry syndrome
  publication-title: Parkinsonism Relat Disord
– volume: 13
  start-page: 867
  year: 2008
  ident: 10.1038/mt.2009.3_bib5
  article-title: Multiple roles of TDP-43 in gene expression, splicing regulation, and human disease
  publication-title: Front Biosci
  doi: 10.2741/2727
– volume: 65
  start-page: 636
  year: 2008
  ident: 10.1038/mt.2009.3_bib15
  article-title: Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis
  publication-title: Arch Neurol
  doi: 10.1001/archneur.65.5.636
– volume: 114
  start-page: 63
  year: 2007
  ident: 10.1038/mt.2009.3_bib20
  article-title: TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease
  publication-title: Acta Neuropathol
  doi: 10.1007/s00401-007-0226-5
– volume: 442
  start-page: 916
  year: 2006
  ident: 10.1038/mt.2009.3_bib8
  article-title: Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
  publication-title: Nature
  doi: 10.1038/nature05016
– volume: 26
  start-page: S1:1
  year: 2008
  ident: 10.1038/mt.2009.3_bib2
  article-title: Pathological spectrum of frontotemporal lobar degeneration
  publication-title: Dement Geriatr Cogn Disord
– volume: 582
  start-page: 2252
  year: 2008
  ident: 10.1038/mt.2009.3_bib21
  article-title: A90V TDP-43 variant results in the aberrant localization of TDP-43 in vitro
  publication-title: FEBS Lett
  doi: 10.1016/j.febslet.2008.05.024
– volume: 17
  start-page: 104
  year: 2007
  ident: 10.1038/mt.2009.3_bib1
  article-title: Frontotemporal lobar degeneration: current concepts in the light of recent advances
  publication-title: Brain Pathol
  doi: 10.1111/j.1750-3639.2007.00055.x
– volume: 920
  start-page: 46
  year: 2000
  ident: 10.1038/mt.2009.3_bib3
  article-title: Classification and description of frontotemporal dementias
  publication-title: Ann NY Acad Sci
  doi: 10.1111/j.1749-6632.2000.tb06904.x
– volume: 65
  start-page: 289
  year: 2006
  ident: 10.1038/mt.2009.3_bib7
  article-title: Characterization of ubiquitinated intraneuronal inclusions in a novel Belgian frontotemporal lobar degeneration family
  publication-title: J Neuropathol Exp Neurol
  doi: 10.1097/01.jnen.0000205147.39210.c7
– volume: 98
  start-page: 10918
  year: 2001
  ident: 10.1038/mt.2009.3_bib26
  article-title: An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.191107398
– volume: 130
  start-page: 1360
  year: 2007
  ident: 10.1038/mt.2009.3_bib14
  article-title: A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology
  publication-title: Brain
  doi: 10.1093/brain/awm069
– volume: 27
  start-page: 1615
  year: 2008
  ident: 10.1038/mt.2009.3_bib13
  article-title: Tau expression levels from various adeno-associated virus vector serotypes produce graded neurodegenerative disease states
  publication-title: Eur J Neurosci
  doi: 10.1111/j.1460-9568.2008.06161.x
– volume: 401
  start-page: 130
  year: 2006
  ident: 10.1038/mt.2009.3_bib25
  article-title: Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model
  publication-title: Neurosci Lett
  doi: 10.1016/j.neulet.2006.03.001
– year: 1998
  ident: 10.1038/mt.2009.3_bib29
– volume: 69
  start-page: 3584
  year: 1995
  ident: 10.1038/mt.2009.3_bib4
  article-title: Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs
  publication-title: J Virol
  doi: 10.1128/JVI.69.6.3584-3596.1995
– volume: 20
  start-page: 64
  year: 2005
  ident: 10.1038/mt.2009.3_bib12
  article-title: Tau gene transfer, but not alpha-synuclein, induces both progressive dopamine neuron degeneration and rotational behavior in the rat
  publication-title: Neurobiol Dis
  doi: 10.1016/j.nbd.2005.02.001
– volume: 13
  start-page: 605
  year: 2002
  ident: 10.1038/mt.2009.3_bib11
  article-title: Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra
  publication-title: Hum Gene Ther
  doi: 10.1089/10430340252837206
– volume: 61
  start-page: 427
  year: 2007
  ident: 10.1038/mt.2009.3_bib10
  article-title: Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations
  publication-title: Ann Neurol
  doi: 10.1002/ana.21147
– reference: 17955025 - Mol Ther. 2008 Jan;16(1):89-96
– reference: 17786458 - Acta Neuropathol. 2008 Jan;115(1):115-22
– reference: 18474740 - Arch Neurol. 2008 May;65(5):636-41
– reference: 17469116 - Ann Neurol. 2007 May;61(5):427-34
– reference: 19155101 - Neurobiol Aging. 2010 Dec;31(12):2091-102
– reference: 17984323 - J Cell Biol. 2007 Nov 5;179(3):485-500
– reference: 17493044 - Brain Pathol. 2007 Jan;17(1):104-14
– reference: 16651890 - J Neuropathol Exp Neurol. 2006 Mar;65(3):289-301
– reference: 17898224 - J Neurosci. 2007 Sep 26;27(39):10530-4
– reference: 17981595 - Front Biosci. 2008;13:867-78
– reference: 16554120 - Neurosci Lett. 2006 Jun 19;401(1-2):130-5
– reference: 17439983 - Brain. 2007 May;130(Pt 5):1386-94
– reference: 11535810 - Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10918-23
– reference: 17023659 - Science. 2006 Oct 6;314(5796):130-3
– reference: 11916484 - Hum Gene Ther. 2002 Mar 20;13(5):605-12
– reference: 18929508 - Trends Mol Med. 2008 Nov;14(11):479-85
– reference: 18723384 - Parkinsonism Relat Disord. 2009 May;15(4):281-6
– reference: 18505686 - FEBS Lett. 2008 Jun 25;582(15):2252-6
– reference: 16137567 - Neurobiol Dis. 2005 Oct;20(1):64-73
– reference: 18088371 - J Neurochem. 2008 May;105(3):797-806
– reference: 18288693 - Ann Neurol. 2008 Apr;63(4):535-8
– reference: 16862116 - Nature. 2006 Aug 24;442(7105):916-9
– reference: 17439980 - Brain. 2007 May;130(Pt 5):1360-74
– reference: 17492294 - Acta Neuropathol. 2007 Jul;114(1):63-70
– reference: 18380664 - Eur J Neurosci. 2008 Apr;27(7):1615-25
– reference: 11193176 - Ann N Y Acad Sci. 2000;920:46-51
– reference: 7745706 - J Virol. 1995 Jun;69(6):3584-96
SSID ssj0011596
Score 2.2267747
Snippet Since the discovery of neuropathological lesions made of TDP-43 and ubiquitin proteins in cases of frontotemporal lobar degeneration (FTLD) and amyotrophic...
SourceID pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 607
SubjectTerms Amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis - genetics
Amyotrophic Lateral Sclerosis - pathology
Animals
Antibodies
Apoptosis
Behavior
Cytoplasm
Dementia - genetics
Dementia - pathology
Dependovirus - genetics
Disease
DNA-Binding Proteins - genetics
Dopamine
Gene therapy
Genetic Vectors
Health sciences
Humans
Mutation
Neurodegeneration
Neuropathology
Neurosciences
Original
Pathology
Proteins
Rats
Toxicology
Transfection
Title Mimicking Aspects of Frontotemporal Lobar Degeneration and Lou Gehrig's Disease in Rats via TDP-43 Overexpression
URI https://dx.doi.org/10.1038/mt.2009.3
https://www.ncbi.nlm.nih.gov/pubmed/19223871
https://www.proquest.com/docview/1792594144
https://www.proquest.com/docview/67102575
https://pubmed.ncbi.nlm.nih.gov/PMC2835101
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fb9MwED6xVkx7QbANyBjDQpPYA9ZS7ObHExp0ZfzomKZN6ptlJw6LtKbrkk7jv-cucVoGg8fYTpTk7uzPPvv7AHZtKqIgiiRHMGy5xDkENz3f8FTaONKhRMemw8mj4-DoXH4Z98duwa102yrbPrHuqNNpQmvk--g4iNQl4v_3VzNOqlGUXXUSGivQJeoy8upwvJhwIdip9blI4ocTtmmZhUS0P6karkrxr_Hob7z557bJ38ah4WN45AAkO2gs_gQe2GIdHjaSkj_XYXXkkuUbMBvlkzyhpXB2UB-oLNk0Y8OascAxUl2ybxjP12xgf9T002QlposUi-fsk73A739TskGTxGF5wU41PuUm1-xscMKlYN8xEuyt20xbbML58PDs4xF3Cgs8QaBVcREL35p-ZK00RgqrA1-bROMUKM2yPo79QSZ1mPoU1XFgRKK1fSfiIAy17qXSF0-hU0wL-xyYJHE_kWFZP5SJL01KIh4msXirCKX2YK_9zypx9OOkgnGp6jS4iNSkIk3MWAkPXi-aXjWcG_c1etsaSzmw0IAAhWPBfc23W4MqF6WlWvqUB68W1RhflDTRhZ3OSxUQBENM68GzxvrLV4oRWuF804Pwjl8sGhBz992aIr-oGbyJ5A77wq3_v9QLWGtzV35vGzrV9dy-RAhUmZ3az3eg--Hw-OQUrwafv_4C14QIVw
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fTxQxEJ4gRuXFKKgsIjRGow807F17--PBGMJ5HnKHxhzJvdV2twubcHvA7qn8U_6NzuyPQwR947Xb3TTtdOabnfb7AF7ZWAReEEiOYNhyiTkENy3X8FjaMNC-RMOmy8nDA69_KD-NO-MF-NXchaFjlY1PLB11PI3oH_k2Gg4idYn4__3pGSfVKKquNhIalVns24sfmLLl7_a6uL6v2-3eh9Fun9eqAjxCcFFwEQrXmk5grTRGCqs9V5tII-yPk6SD8c5LpPZjlyw59IyItLZtEXq-r3Urlq7A796Buxh4XUr2_PE8wUNwVeqBkaQQJyzVMBmJYHtSVNyY4l_x7zq-_fuY5h9xr_cIHtaAle1UFvYYFmy2DPcqCcuLZbg_rIvzK3A2TCdpRL_e2U55gTNn04T1SoaEmgHrhA3Qf5yzrj0q6a7JKpjOYmyesY_2GOf7Tc66VdGIpRn7qvEr31PNRt0vXAr2GXee_Vkf3s2ewOGtzP1TWMymmV0FJklMUCTY1vFl5EoTk2iIiSy-KnypHXjbzLOKarpzUt04UWXZXQRqUpAGZ6iEAy_nXU8rjo-bOm01i6VqcFKBDoWx56bu682Cqtor5OrShh3YnD_G_UxFGp3Z6SxXHkE-xNAOPKtW_3JIIUI5zG8d8K_YxbwDMYVffZKlxyVjOJHqoe9d-_-gNuFBfzQcqMHewf5zWGrqZm5rHRaL85l9gfCrMBulzTP4dtub7Dd4KUMR
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mimicking+Aspects+of+Frontotemporal+Lobar+Degeneration+and+Lou+Gehrig%27s+Disease+in+Rats+via+TDP-43+Overexpression&rft.jtitle=Molecular+therapy&rft.au=Tatom%2C+Jason+B&rft.au=Wang%2C+David+B&rft.au=Dayton%2C+Robert+D&rft.au=Skalli%2C+Omar&rft.date=2009-04-01&rft.pub=Nature+Publishing+Group&rft.issn=1525-0016&rft.eissn=1525-0024&rft.volume=17&rft.issue=4&rft.spage=607&rft.epage=613&rft_id=info:doi/10.1038%2Fmt.2009.3&rft_id=info%3Apmid%2F19223871&rft.externalDocID=PMC2835101
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1525-0016&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1525-0016&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1525-0016&client=summon